Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00670904 · ClinicalTrials.gov registry record · NA
Randomized Trial Assessing the Effectiveness of a Pharmacist-Delivered Program for Smoking Cessation
A NA study, sponsored by University of Montana.
- Completed
- Registry status
- NA
- Development phase
- 101
- Enrollment target
NCT00670904: Completed NA study, sponsored by University of Montana.
NCT00670904 is a NA study that has completed, run by University of Montana. The registered enrollment target is 101 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00670904, a NA study, has completed, sponsored by University of Montana.
- COMPLETED
- Registry status
- NA
- Development phase
- 101 participants
- Enrollment target
Study Summary
This randomized trial compared the effectiveness of a three session pharmacist-delivered group program for smoking versus one 5 to 10 minute standard care session delivered over the telephone on 7-day point prevalence quit rates. Participants in both groups were offered their choice of bupropion IR or nicotine patch at no cost. At 6 months after the established quit date, self-reported cessation was biochemically verified using tests for urinary cotinine.
Interventions
- OTHER Pharmacist-delivered group program for smoking cessation
- OTHER Brief standard care session for smoking cessation delivered over the telephone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2005-10 |
| Est. Completion | 2007-11 |
| Phase | NA |
What the finished NCT00670904 record still lists
NCT00670904 is an interventional study that assigns participants to a tested intervention. The registered 101 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 2 interventions - of which Pharmacist-delivered group program for smoking cessation is the first listed.
NCT00670904 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00670904 about?
NCT00670904 is a clinical study titled "Randomized Trial Assessing the Effectiveness of a Pharmacist-Delivered Program for Smoking Cessation". This randomized trial compared the effectiveness of a three session pharmacist-delivered group program for smoking versus one 5 to 10 minute standard care session delivered over the telephone on 7-day point prevalence quit rates. Participants in both groups were offered their choice of bupropion IR ...
What is the current status of trial NCT00670904?
This trial is currently completed. It is a NA study. The enrollment target is 101 participants. The study started on 2005-10. Estimated completion is 2007-11.
What interventions are being tested in trial NCT00670904?
The interventions under investigation include: Pharmacist-delivered group program for smoking cessation (OTHER), Brief standard care session for smoking cessation delivered over the telephone (OTHER).
Who is sponsoring clinical trial NCT00670904?
This trial is sponsored by University of Montana, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00670904's enrollment target sits among peer trials
101 840th of 2000 higher than 1,161 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04033497 · 101 participants · NA
Treatment Response Assessment Maps to Delineate Necrosis From Tumor After Stereotactic Radiation in Brain Metastases
- NCT05111574 · 101 participants · Phase 2
Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery
- NCT05984680 · 101 participants
COPD Care Pathway Among Patients With Cancer
- NCT06266299 · 101 participants · Phase 1
A Study of KK2269 in Adult Participants With Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia